QDx Pathology Services is a national, independent, and full-service anatomical and molecular pathology laboratory founded in 2006. The company prides itself on offering boutique service with national coverage, focusing on providing diagnostic excellence in Health Care industry. With a CAP-certified facility and a staff of experienced, board-certified pathologists and cytotechnologists, QDx Pathology is committed to delivering high standards of care. Interestingly, the company has recently positioned itself as the official lab partner for EUA FDA Approved COVID-19 Patient Take Home Tests, showcasing its agility in response to the pandemic. This strategic move aims to support the increased testing capacity for COVID-19, placing a strong emphasis on contributing to the wellbeing of the community and facilitating a safe return to work and normalcy. With its dedication to quality diagnostic services and its involvement in crucial healthcare challenges such as #CovidTesting, QDx Pathology presents an attractive investment opportunity for investors seeking resilience and innovation in the healthcare sector.
There is no investment information
No recent news or press coverage available for QDx Pathology Services.